FDA Inspection 1043586 — Huntington Reproductive Center Medical Group

Huntington Reproductive Center Medical Group — FEI 3006501046

The FDA completed an inspection of Huntington Reproductive Center Medical Group on January 19, 2018 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 19, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Los Angeles, CA (United States)